ROYAL BANK OF CANADA - ACTINIUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,0000.0%8,448
+25.5%
0.00%
Q2 2023$49,000
+6.5%
6,734
+38.5%
0.00%
Q1 2023$46,000
+58.6%
4,863
+82.6%
0.00%
Q4 2022$29,0002,663
+4571.9%
0.00%
Q3 2022$0
-100.0%
57
-86.0%
0.00%
Q1 2022$2,000406
+6666.7%
0.00%
Q4 2021$060.0%0.00%
Q3 2021$060.0%0.00%
Q2 2021$060.0%0.00%
Q1 2021$060.0%0.00%
Q4 2020$060.0%0.00%
Q3 2020$060.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$702,0000.41%
Rubric Capital Management LP 294,683$2,299,0000.17%
Interchange Capital Partners, LLC 24,420$190,0000.10%
GOODWIN DANIEL L 20,000$156,0000.09%
Consonance Capital Management LP 88,428$690,0000.06%
DCM Advisors, LLC 13,300$104,0000.06%
Virtu Financial LLC 27,524$215,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 68,899$537,0000.01%
Lindbrook Capital, LLC 1,000$8,0000.00%
ExodusPoint Capital Management, LP 11,900$93,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders